Evidence map›Paper›PMID 32694205›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

A single-cell Raman-based platform to identify developmental stages of human pluripotent stem cell-derived neurons.

Chia-Chen Hsu, Jiabao Xu, Bas Brinkhof, Hui Wang, Zhanfeng Cui, Wei E Huang, Hua Ye

Abstract readEvaluation Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Noninvasive andThe Analyst · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chia-Chen HsuInstitute of Biomedical Engineering, University of Oxford, OX3 7DQ Oxford, United Kingdom.ORCID 0000-0003-4408-8297
Jiabao XuDepartment of Engineering Science, University of Oxford, OX1 3PJ Oxford, United Kingdom.ORCID 0000-0002-1285-9408
Bas BrinkhofInstitute of Biomedical Engineering, University of Oxford, OX3 7DQ Oxford, United Kingdom.ORCID 0000-0003-3617-0709
Hui WangInstitute of Biomedical Engineering, University of Oxford, OX3 7DQ Oxford, United Kingdom.
Zhanfeng CuiInstitute of Biomedical Engineering, University of Oxford, OX3 7DQ Oxford, United Kingdom.ORCID 0000-0002-9251-9752
Wei E HuangDepartment of Engineering Science, University of Oxford, OX1 3PJ Oxford, United Kingdom wei.huang@eng.ox.ac.uk hua.ye@eng.ox.ac.uk.ORCID 0000-0003-1302-6528
Hua YeInstitute of Biomedical Engineering, University of Oxford, OX3 7DQ Oxford, United Kingdom; wei.huang@eng.ox.ac.uk hua.ye@eng.ox.ac.uk.ORCID 0000-0001-7613-6041

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cells with the capability to self-renew and differentiate into multiple cell derivatives provide platforms for drug screening and promising treatment options for a wide variety of neural diseases. Nevertheless, clinical applications of stem cells have been hindered partly owing to a lack of standardized techniques to characterize cell molecular profiles noninvasively and comprehensively. Here, we demonstrate that a label-free and noninvasive single-cell Raman microspectroscopy (SCRM) platform was able to identify neural cell lineages derived from clinically relevant human induced pluripotent stem cells (hiPSCs). By analyzing the intrinsic biochemical profiles of single cells at a large scale (8,774 Raman spectra in total), iPSCs and iPSC-derived neural cells can be distinguished by their intrinsic phenotypic Raman spectra. We identified a Raman biomarker from glycogen to distinguish iPSCs from their neural derivatives, and the result was verified by the conventional glycogen detection assays. Further analysis with a machine learning classification model, utilizing t-distributed stochastic neighbor embedding (t-SNE)-enhanced ensemble stacking, clearly categorized hiPSCs in different developmental stages with 97.5% accuracy. The present study demonstrates the capability of the SCRM-based platform to monitor cell development using high content screening with a noninvasive and label-free approach. This platform as well as our identified biomarker could be extensible to other cell types and can potentially have a high impact on neural stem cell therapy.

Indexed as

Cell DifferentiationHumansInduced Pluripotent Stem CellsNeuronsSingle-Cell AnalysisSpectrum Analysis, Ramanbiomarkerdifferentiationmachine learningneural stem cellRaman spectroscopy

Identifiers

PMID32694205
PMCPMC7414136

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.